Senseonics Holdings Inc (NYSEAMERICAN:SENS) saw a large growth in short interest during the month of January. As of January 12th, there was short interest totalling 3,946,300 shares, a growth of 2.1% from the December 29th total of 3,864,087 shares. Currently, 8.1% of the company’s stock are sold short. Based on an average trading volume of 389,608 shares, the short-interest ratio is presently 10.1 days.
In other Senseonics news, major shareholder Peter J. Barris sold 139,645 shares of the stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $2.63, for a total value of $367,266.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 34.10% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Goldman Sachs Group Inc. purchased a new stake in shares of Senseonics during the 2nd quarter worth approximately $276,000. Raymond James Financial Services Advisors Inc. increased its stake in shares of Senseonics by 221.4% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 263,562 shares of the company’s stock worth $474,000 after purchasing an additional 181,562 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of Senseonics during the 3rd quarter worth approximately $116,000. Susquehanna International Group LLP bought a new position in Senseonics in the 2nd quarter worth approximately $155,000. Finally, Citadel Advisors LLC bought a new position in Senseonics in the 3rd quarter worth approximately $194,000. Institutional investors own 30.66% of the company’s stock.
Senseonics (SENS) traded down $0.06 during trading hours on Wednesday, reaching $2.90. 371,400 shares of the company’s stock traded hands, compared to its average volume of 343,487. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.81 and a current ratio of 2.93. The stock has a market cap of $404.79 and a price-to-earnings ratio of -5.80. Senseonics has a 52-week low of $1.26 and a 52-week high of $3.67.
Senseonics (NYSEAMERICAN:SENS) last issued its quarterly earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.13). Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The company had revenue of $2.10 million during the quarter, compared to analyst estimates of $1.51 million. The company’s revenue was up 425.0% on a year-over-year basis. analysts expect that Senseonics will post -0.54 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Senseonics Holdings Inc (SENS) Short Interest Up 2.1% in January” was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/01/24/senseonics-holdings-inc-sens-short-interest-up-2-1-in-january.html.
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.